The global clinical lab automation market is projected to reach $3.72 billion by 2030, at a CAGR of 7.8% from 2023 to 2030.
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising global geriatric population, increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. Furthermore, increasing demand for automated instruments due to technological advancements, efficiency, and accuracy; technological advancements in molecular diagnostics; and emerging economies provide significant growth opportunities for this market.
However, the high costs of advanced clinical lab automation equipment and funding and infrastructure limitations in developing countries may restrain the growth of this market. Additionally, equipment maintenance and repair costs and concerns over the security and privacy of patient data pose a major challenge for the players operating in this market.
Among products, in 2023, the systems segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to the increased focus on drug development, and the advantages of automated liquid handling systems to increase efficiency and productivity while reducing errors.
Among end users, in 2023, the hospital laboratories segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to factors such as rising healthcare expenditures, continuous improvements in healthcare infrastructure, and the utilization of advanced techniques and technologies.
An in-depth analysis of the geographical scenario of the global clinical lab automation market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.
In 2023, North America is expected to account for the largest share of the global clinical lab automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global clinical lab automation market.
The key players operating in the global clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising global geriatric population, increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. Furthermore, increasing demand for automated instruments due to technological advancements, efficiency, and accuracy; technological advancements in molecular diagnostics; and emerging economies provide significant growth opportunities for this market.
However, the high costs of advanced clinical lab automation equipment and funding and infrastructure limitations in developing countries may restrain the growth of this market. Additionally, equipment maintenance and repair costs and concerns over the security and privacy of patient data pose a major challenge for the players operating in this market.
Among products, in 2023, the systems segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to the increased focus on drug development, and the advantages of automated liquid handling systems to increase efficiency and productivity while reducing errors.
Among end users, in 2023, the hospital laboratories segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to factors such as rising healthcare expenditures, continuous improvements in healthcare infrastructure, and the utilization of advanced techniques and technologies.
An in-depth analysis of the geographical scenario of the global clinical lab automation market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.
In 2023, North America is expected to account for the largest share of the global clinical lab automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global clinical lab automation market.
The key players operating in the global clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Scope of the Report:
Clinical Lab Automation Market Assessment-by Product
- Systems
- Automated Liquid Handling Systems
- Automated ELISA Systems
- Automated Nucleic Acid Purification Systems
- Automated Microplate Readers
- Other Systems
- Clinical Lab Automation Software
Clinical Lab Automation Market Assessment-by End User
- Hospital Laboratories
- Diagnostic Laboratories
- Other End Users
Note: Other end users include blood banks, forensic labs, and clinical research organizations
Clinical Lab Automation Market Assessment-by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Table of Contents
1. Introduction
2. Research Methodology
4. Market Insights
5. Clinical Lab Automation Market Assessment-by Product
6. Clinical Lab Automation Market Assessment-by End User
7. Clinical Lab Automation Market Assessment-by Geography
8. Competition Analysis
9. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)
10. Appendix
List of Tables
List of Figures
Companies Mentioned
- Thermo Fisher Scientific Inc. (U.S.)
- Bio-Rad Laboratories Inc. (U.S.)
- Danaher Corporation (U.S.)
- Revvity Inc. (Formerly known as PerkinElmer Inc.) (U.S.)
- F. Hoffmann-La Roche AG (Switzerland)
- Agilent Technologies Inc. (U.S.)
- Waters Corporation (U.S.)
- Tecan Group Ltd. (Switzerland)
- Siemens Healthineers AG (Germany)
- Becton, Dickinson, Company (U.S.)
- Abbott Laboratories (U.S.)
- Hudson Robotics Inc. (U.S.)
- Hamilton Company (U.S.)
